Agomab Therapeutics NV (AGMB)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 51
0
0%
$
616.09M Market Cap
- P/E Ratio
- Div Yield
33,102 Volume
- Eps
$ 12.51
Previous Close Investors:
Want to track AGMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agomab Therapeutics NV Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MDP Madelyn D. Purcell Pfizer Inc | 75,000 | $813,750 | $907,897.5 | $94,147.5 | 11.57% |
 Regan O'Neill Burkehill Global Management LP | 35,000 | $367,150 | $427,000 | $59,850 | 16.3% |
 Raymond Debbane Siren, L.L.C. | 411,250 | $4.31M | $4.94M | $625,099.51 | 14.49% |
